FDA Hits Compounders With Letters Over Sterility Issues, Misbranding By Sam | April 11, 2016 Two compounding operations are facing FDA allegations of producing adulterated drugs and doing so without prescriptions following agency inspections. Source: Drug GMP Report Posted in Drug GMP Report